{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T02:04:26Z","timestamp":1792202666745,"version":"4.4.0"},"reference-count":40,"publisher":"BMJ","issue":"7","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","award":["Programme Grants for Applied Research Programme (g"],"award-info":[{"award-number":["Programme Grants for Applied Research Programme (g"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2021,5,26]]},"published-print":{"date-parts":[[2021,7]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Most individuals treated for heroin use disorder receive opioid agonist treatment (OAT)(methadone or buprenorphine). However, OAT is associated with high attrition and persistent, occasional heroin use. There is some evidence for the effectiveness of contingency management (CM), a behavioural intervention involving modest financial incentives, in encouraging drug abstinence when applied adjunctively with OAT. UK drug services have a minimal track record of applying CM and limited resources to implement it. We assessed a CM intervention pragmatically adapted for ease of implementation in UK drug services to promote heroin abstinence among individuals receiving OAT.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Cluster randomised controlled trial.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting and participants<\/jats:title>\n                    <jats:p>552 adults with heroin use disorder (target 660) enrolled from 34 clusters (drug treatment clinics) in England between November 2012 and October 2015.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions<\/jats:title>\n                    <jats:p>Clusters were randomly allocated 1:1:1 to OAT plus 12\u00d7 weekly appointments with: (1) CM targeted at opiate abstinence at appointments (CM Abstinence); (2) CM targeted at on-time attendance at appointments (CM Attendance); or (3) no CM (treatment as usual; TAU). Modifications included monitoring behaviour weekly and fixed incentives schedule.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Measurements<\/jats:title>\n                    <jats:p>Primary outcome: heroin abstinence measured by heroin-free urines (weeks 9\u201312). Secondary outcomes: heroin abstinence 12 weeks after discontinuation of CM (weeks 21\u201324); attendance; self-reported drug use, physical and mental health.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>CM Attendance was superior to TAU in encouraging heroin abstinence. Odds of a heroin-negative urine in weeks 9\u201312 was statistically significantly greater in CM Attendance compared with TAU (OR=2.1; 95% CI 1.1 to 3.9; p=0.030). CM Abstinence was not superior to TAU (OR=1.6; 95% CI 0.9 to 3.0; p=0.146) or CM Attendance (OR=1.3; 95% CI 0.7 to 2.4; p=0.438) (not statistically significant differences). Reductions in heroin use were not sustained at 21\u201324 weeks. No differences between groups in self-reported heroin use.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>A pragmatically adapted CM intervention for routine use in UK drug services was moderately effective in encouraging heroin abstinence compared with no CM only when targeted at attendance. CM targeted at abstinence was not effective.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>ISRCTN 01591254.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2020-046371","type":"journal-article","created":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T12:48:55Z","timestamp":1625143735000},"page":"e046371","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":13,"title":["Using a pragmatically adapted, low-cost contingency management intervention to promote heroin abstinence in individuals undergoing treatment for heroin use disorder in UK drug services (PRAISE): a cluster randomised trial"],"prefix":"10.1136","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3581-1703","authenticated-orcid":false,"given":"Nicola","family":"Metrebian","sequence":"first","affiliation":[{"name":"Addictions, King's College London, Institute of Psychiatry, Psychology and Neuroscience, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Weaver","sequence":"additional","affiliation":[{"name":"Department of Mental Health & Social Work, Middlesex University, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberley","family":"Goldsmith","sequence":"additional","affiliation":[{"name":"Biostatistics and Health Informatics, King's College London, Institute of Psychiatry, Psychology and Neuroscience, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Pilling","sequence":"additional","affiliation":[{"name":"Centre for Outcomes, Research and Effectiveness, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Hellier","sequence":"additional","affiliation":[{"name":"Biostatistics and Health Informatics, King's College London, Institute of Psychiatry, Psychology and Neuroscience, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Pickles","sequence":"additional","affiliation":[{"name":"Biostatistics and Health Informatics, King's College London, Institute of Psychiatry, Psychology and Neuroscience, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Shearer","sequence":"additional","affiliation":[{"name":"Health Services and Population Research, King's College London, Institute of Psychiatry, Psychology and Neuroscience, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7084-1495","authenticated-orcid":false,"given":"Sarah","family":"Byford","sequence":"additional","affiliation":[{"name":"Health Services and Population Research, King's College London, Institute of Psychiatry, Psychology and Neuroscience, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke","family":"Mitcheson","sequence":"additional","affiliation":[{"name":"Addictions, South London and Maudsley NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prun","family":"Bijral","sequence":"additional","affiliation":[{"name":"Management Offices, Change Grow Live, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Bogdan","sequence":"additional","affiliation":[{"name":"Sankey House, Essex Partnership University NHS Foundation Trust, Pitsea,Essex, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Owen","family":"Bowden-Jones","sequence":"additional","affiliation":[{"name":"Addictions and Substance Misuse, Central and North West London NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Day","sequence":"additional","affiliation":[{"name":"Addiction Services, Birmingham and Solihull Mental Health NHS Foundation Trust, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Dunn","sequence":"additional","affiliation":[{"name":"Drugs and Alcohol Services, Camden and Islington NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Glasper","sequence":"additional","affiliation":[{"name":"Substancce Misuse Service, Sussex Partnership NHS Foundation Trust, Worthing, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Finch","sequence":"additional","affiliation":[{"name":"Addictions, South London and Maudsley NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam","family":"Forshall","sequence":"additional","affiliation":[{"name":"Drug and Alcohol Services, Avon and Wiltshire Mental Health Partnership NHS Trust, Bath, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shabana","family":"Akhtar","sequence":"additional","affiliation":[{"name":"Addiction Services, Birmingham and Solihull Mental Health NHS Foundation Trust, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jalpa","family":"Bajaria","sequence":"additional","affiliation":[{"name":"Sankey House, Essex Partnership University NHS Foundation Trust, Pitsea,Essex, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmel","family":"Bennett","sequence":"additional","affiliation":[{"name":"Addiction Services, Birmingham and Solihull Mental Health NHS Foundation Trust, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Bishop","sequence":"additional","affiliation":[{"name":"Centre for Outcomes, Research and Effectiveness, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikki","family":"Charles","sequence":"additional","affiliation":[{"name":"Addictions, King's College London, Institute of Psychiatry, Psychology and Neuroscience, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare","family":"Davey","sequence":"additional","affiliation":[{"name":"Drug and Alcohol Services, Avon and Wiltshire Mental Health Partnership NHS Trust, Bath, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roopal","family":"Desai","sequence":"additional","affiliation":[{"name":"Addictions, King's College London, Institute of Psychiatry, Psychology and Neuroscience, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5990-8150","authenticated-orcid":false,"given":"Claire","family":"Goodfellow","sequence":"additional","affiliation":[{"name":"Centre for Outcomes, Research and Effectiveness, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farjana","family":"Haque","sequence":"additional","affiliation":[{"name":"Addictions, King's College London, Institute of Psychiatry, Psychology and Neuroscience, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Little","sequence":"additional","affiliation":[{"name":"Centre for Outcomes, Research and Effectiveness, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hortencia","family":"McKechnie","sequence":"additional","affiliation":[{"name":"Addictions, King's College London, Institute of Psychiatry, Psychology and Neuroscience, London, UK"},{"name":"Centre for Mental Health, Imperial College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franziska","family":"Mosler","sequence":"additional","affiliation":[{"name":"Addictions, King's College London, Institute of Psychiatry, Psychology and Neuroscience, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo","family":"Morris","sequence":"additional","affiliation":[{"name":"Drug and Alcohol Services, Avon and Wiltshire Mental Health Partnership NHS Trust, Bath, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5308-1957","authenticated-orcid":false,"given":"Julian","family":"Mutz","sequence":"additional","affiliation":[{"name":"Addictions, King's College London, Institute of Psychiatry, Psychology and Neuroscience, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Pauli","sequence":"additional","affiliation":[{"name":"Addiction Services, Birmingham and Solihull Mental Health NHS Foundation Trust, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilkushi","family":"Poovendran","sequence":"additional","affiliation":[{"name":"Centre for Mental Health, Imperial College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Phillips","sequence":"additional","affiliation":[{"name":"Sankey House, Essex Partnership University NHS Foundation Trust, Pitsea,Essex, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Strang","sequence":"additional","affiliation":[{"name":"Addictions, King's College London, Institute of Psychiatry, Psychology and Neuroscience, London, UK"},{"name":"Addictions, South London and Maudsley NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2021,7,1]]},"reference":[{"key":"2025121409392631000_11.7.e046371.1","unstructured":"World Health Organization . Guidelines for the Psychosocially assisted pharmacological treatment of opioid dependence. WHO Library, 2009. ISBN: 978 92 4 154754 3."},{"key":"2025121409392631000_11.7.e046371.2","unstructured":"National Institute for Health and Care Excellence (NICE) . Drug misuse; 2006."},{"key":"2025121409392631000_11.7.e046371.3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2004.00752.x"},{"key":"2025121409392631000_11.7.e046371.4","unstructured":"National Treatment Agency for Substance Misuse (NTA) . From access to recovery: analysing six years of drug treatment data, 2012."},{"key":"2025121409392631000_11.7.e046371.5","unstructured":"Skinner BF . The Behavior of Organisms: An Experimental Analysis 1966, Skinner Foundation. In: Skinner B , ed. The behavior of organisms: an experimental analysis. Oxford, England: Appleton-Century, 1938."},{"key":"2025121409392631000_11.7.e046371.6","unstructured":"Petry NM . Contingency management for substance abuse treatment: a guide to implementing this Evidence- based practice. Routledge, 2012. ISBN: 978-0-415-88289-7."},{"key":"2025121409392631000_11.7.e046371.7","doi-asserted-by":"publisher","DOI":"10.1037\/0022-006X.73.6.1005"},{"key":"2025121409392631000_11.7.e046371.8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2006.01311.x"},{"key":"2025121409392631000_11.7.e046371.9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2006.01581.x"},{"key":"2025121409392631000_11.7.e046371.10","unstructured":"Higgins ST , Sigmon SC , Heil SH . Contingency management in the treatment of substance use disorders: trends in the literature. In: Ruiz P , Strain E , eds. Lowinson and Ruiz\u2019s Substance Abuse: A comprehensive Textbook. Philadelphia PA: Lippincott Williams and Wilkins, 2011: 603\u201321."},{"key":"2025121409392631000_11.7.e046371.11","doi-asserted-by":"crossref","unstructured":"Davis DR , Kurti AN , Skelly JM . A review of the literature on contingency management in the treatment of substance misuse disorders 2009-2014. Preventive Medicine, 2016.","DOI":"10.1016\/j.ypmed.2016.08.008"},{"key":"2025121409392631000_11.7.e046371.12","unstructured":"European Monitoring Centre for Drugs and Drug Addiction . How can contingency management support treatment for substance use disorders? A systematic review, EMCDDA papers, publications office of the European Union, Luxembourg, 2016."},{"key":"2025121409392631000_11.7.e046371.13","doi-asserted-by":"crossref","unstructured":"Amato L , Minozzi S , Davoli M , et al . Cochrane database of systematic reviews: psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence, 2011.","DOI":"10.1002\/14651858.CD004147.pub4"},{"key":"2025121409392631000_11.7.e046371.14","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.drugalcdep.2017.05.028","article-title":"Contingency management interventions for non-prescribed drug use during treatment for opiate addiction: a systematic review and meta-analysis","volume":"178","author":"Ainscough","year":"2017","journal-title":"Drug Alcohol Depend"},{"key":"2025121409392631000_11.7.e046371.15","unstructured":"National Collaborating Centre for Mental Health . Drug misuse: psychosocial interventions. London: British Psychological Society and The Royal College of psychiatrists, 2008."},{"key":"2025121409392631000_11.7.e046371.16","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)60196-3"},{"key":"2025121409392631000_11.7.e046371.17","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1111\/add.13385","article-title":"An economic evaluation of contingency management for completion of hepatitis B vaccination in those on treatment for opiate dependence","volume":"111","author":"Rafia","year":"2016","journal-title":"Addiction"},{"key":"2025121409392631000_11.7.e046371.18","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.cct.2018.06.008","article-title":"Positive Reinforcement targeting Abstinence in Substance misuse (PRAISe): Cluster RCT & Process Evaluation of Contingency Management","volume":"71","author":"Metrebian","year":"2018","journal-title":"Contemporary Clinical Trials"},{"key":"2025121409392631000_11.7.e046371.19","unstructured":"Metrebian N , Weaver T , Pilling S . Developing a UK evidence base for contingency management in addiction treatment: incentive-based interventions to improve treatments to reduce drug use and associated harms. final report. London: National Institute for Heath Research., 2018."},{"key":"2025121409392631000_11.7.e046371.20","unstructured":"NTA . Models of care for the treatment of drug misusers: update 2006. London: NTA, 2006."},{"key":"2025121409392631000_11.7.e046371.21","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(99)00049-6"},{"key":"2025121409392631000_11.7.e046371.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpr.2010.02.005"},{"key":"2025121409392631000_11.7.e046371.23","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.1991.tb01706.x"},{"key":"2025121409392631000_11.7.e046371.24","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.1993.tb02093.x"},{"key":"2025121409392631000_11.7.e046371.25","first-page":"733","article-title":"Development and validation of a multidimensional instrument for assessing outcome of treatment among opiate users: the opiate treatment index","volume":"87","author":"Darke","year":"1992","journal-title":"Addiction"},{"key":"2025121409392631000_11.7.e046371.26","unstructured":"Sf-36 version II. QualityMetric incorporated."},{"key":"2025121409392631000_11.7.e046371.27","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1983.tb09716.x"},{"key":"2025121409392631000_11.7.e046371.28","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1080\/10503307.2011.643253","article-title":"Two short forms of the Agnew relationship measure: the ARM-5 and ARM-12","volume":"22","author":"Cahill","year":"2012","journal-title":"Psychother Res"},{"key":"2025121409392631000_11.7.e046371.29","doi-asserted-by":"publisher","DOI":"10.1037\/1064-1297.5.3.256"},{"key":"2025121409392631000_11.7.e046371.30","doi-asserted-by":"publisher","DOI":"10.1093\/her\/cyl148"},{"key":"2025121409392631000_11.7.e046371.31","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.112.111583"},{"key":"2025121409392631000_11.7.e046371.32","doi-asserted-by":"publisher","DOI":"10.1016\/0168-8510(90)90421-9"},{"key":"2025121409392631000_11.7.e046371.33","doi-asserted-by":"publisher","DOI":"10.1097\/01.jom.0000052967.43131.51"},{"key":"2025121409392631000_11.7.e046371.34","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60349-2"},{"key":"2025121409392631000_11.7.e046371.35","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a009511"},{"key":"2025121409392631000_11.7.e046371.36","unstructured":"Department of Health and devolved administrations . Drug misuse and dependence: UK guidelines on clinical management drug misuse and dependence. Department of Health, 2007."},{"key":"2025121409392631000_11.7.e046371.37","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2011.05.016"},{"key":"2025121409392631000_11.7.e046371.38","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2011.11.011"},{"key":"2025121409392631000_11.7.e046371.39","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jsat.2016.06.012","article-title":"The Effectiveness of Ultra-Low Magnitude Reinforcers: Findings From a \"Real-World\" Application of Contingency Management","volume":"72","author":"Kropp","year":"2017","journal-title":"J Subst Abuse Treat"},{"key":"2025121409392631000_11.7.e046371.40","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.drugalcdep.2017.12.020","article-title":"The National implementation of contingency management (cm) in the Department of Veterans Affairs: attendance at cm sessions and substance use outcomes","volume":"185","author":"DePhilippis","year":"2018","journal-title":"Drug Alcohol Depend"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2020-046371","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T17:39:33Z","timestamp":1765733973000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2020-046371"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":40,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2021,7,1]]},"published-print":{"date-parts":[[2021,7]]}},"alternative-id":["10.1136\/bmjopen-2020-046371"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2020-046371","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7]]}}}